The intravenous administration of immunoliposomes with TRscFv to mice with xenotransplants of carcinomas of the head and neck, demonstrated consistent transport to the tumor site and efficient expression of the tumor suppressor gene p53 in comparison with liposomes without an associated ligand. The gene discussed is TP53; the disease is neoplasm.